The Journal of Experimental Medicine
Randox
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online October 8, 2007
doi:10.1084/jem.20071262
The Journal of Experimental Medicine, Vol. 204, No. 11, 2629-2639
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Schneider et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schneider, L. A.
Right arrow Articles by Rodewald, H.-R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schneider, L. A.
Right arrow Articles by Rodewald, H.-R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Molecular mechanism of mast cell–mediated innate defense against endothelin and snake venom sarafotoxin

Lars A. Schneider1, Susan M. Schlenner1, Thorsten B. Feyerabend1, Markus Wunderlin2, and Hans-Reimer Rodewald1

1 Institute for Immunology, 2 Section for Mass Spectrometry, Institute for Organic Chemistry II, University of Ulm, D-89081 Ulm, Germany

CORRESPONDENCE H.R. Rodewald: hans-reimer.rodewald{at}uni-ulm.de

Mast cells are protective against snake venom sarafotoxins that belong to the endothelin (ET) peptide family. The molecular mechanism underlying this recently recognized innate defense pathway is unknown, but secretory granule proteases have been invoked. To specifically disrupt a single protease function without affecting expression of other proteases, we have generated a mouse mutant selectively lacking mast cell carboxypeptidase A (Mc-cpa) activity. Using this mutant, we have now identified Mc-cpa as the essential protective mast cell enzyme. Mass spectrometry of peptide substrates after cleavage by normal or mutant mast cells showed that removal of a single amino acid, the C-terminal tryptophan, from ET and sarafotoxin by Mc-cpa is the principle molecular mechanism underlying this very rapid mast cell response. Mast cell proteases can also cleave ET and sarafotoxin internally, but such "nicking" is not protective because intramolecular disulfide bridges maintain peptide function. We conclude that mast cells attack ET and sarafotoxin exactly at the structure required for toxicity, and hence sarafotoxins could not "evade" Mc-cpa's substrate specificity without loss of toxicity.


Abbreviations used: ET, endothelin; Mc-cpa, mast cell carboxypeptidase A; Mcp, mast cell protease; PEC, peritoneal exudate cell; S6b, sarafotoxin 6b.

L.A. Schneider, S.M. Schlenner, and T.B. Feyerabend contributed equally to this paper.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS